Chief Physician, Doctoral Supervisor. Leading expert and chief specialist in Hematology, recipient of the 6th National Renowned Doctor Award
Affiliated HospitalShanghai Children's Medical Center (National Children's Medical Center), affiliated with Shanghai Jiao Tong University School of Medicine
→
Secretary-General of the National Expert Committee on Childhood Leukemia, Vice Chairman of the Leukemia Group of the National Expert Committee on Childhood Hematologic Diseases and Malignant Tumors, Vice Chairman of the Hematologic Oncology Committee of the Pediatric Branch of the Chinese Medical Doctor Association, and Chairman of the Scientific Committee of the Collaborative Group on Childhood Acute Lymphoblastic Leukemia of the Chinese Anti-Cancer Association. Leads the world's largest collaborative group on childhood acute lymphoblastic leukemia, achieving an internationally advanced survival rate (91%); spearheaded the construction of a childhood leukemia registry system, playing a positive role in the rational allocation of national resources, the formulation of health policies, the strengthening of management, and the standardization of treatment protocols. Pioneered targeted therapy for refractory leukemia based on molecular mechanism analysis, conducting over 200 consultations nationwide annually. Undertakes 3 national-level research projects, with findings published in authoritative journals such as JAMA Oncol, Lancet Oncol, Nature Genetics, and Blood. Specializes in refractory/relapsed acute leukemia, various types of childhood leukemia, and lymphoma.